Nucleic Acid Testing Market Growth Analysis 2022-28
The global nucleic acid testing market size was valued at USD x billion in 2021, growing at a CAGR of x% during the forecast period 2022-2028. Nucleic acid testing (NAT) is a molecular method for detecting viruses, bacteria, and pathogenic nucleic acids in a patient's blood, tissue, or urine. It is used for forensic purposes as well as to diagnose infections transferred through blood transfusions, hereditary disorders, and cancer. Nucleic acid (NA) extraction, target NA amplification, and target amplicon NA detection are all part of the process. Kits and consumables for polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA), and NA sequence-based amplification (NASBA) techniques are included in the testing.
View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-nucleic-acid-testing-market/
One of the important factors driving the market's growth is the increasing incidence of infectious bacterial and viral infections around the world. In addition, the growing need for improved diagnostic systems is propelling the industry forward. In line with this, the emergence of the coronavirus illness (COVID-19) has boosted demand for NAT antigen detection technologies. NAT is frequently utilised to manage infectious diseases effectively and accurately identify the infecting agent. Other growth-inducing variables include technology improvements such as the development of novel biological diagnostic tools, including signal and probe amplification systems. These cutting-edge methods aid in the early identification of sickness and the reduction of the virus's infectious phase. Other factors, such as intensive research and development (R&D) activities and advancements in healthcare infrastructure, are expected to fuel the market even further.
The global Nucleic Acid Testing Market segmentation:
- By Technique: Probe Amplification, Target Amplification, Signal Amplification
- By Application: Cancer, Infectious Diseases, Genetics, Personalized Medicine
- By End User: Hospitals, Diagnostic Centers, Research organizations, Others
Owing to the improved healthcare infrastructure and the increased prevalence of infectious diseases, the United States is predicted to be the leading nucleic acid amplification testing market. NAAT was implemented in Canada by Canadian Blood Services, which ensures a safe blood supply by detecting low quantities of viral genes. These programmes boost the number of people who take these tests. Furthermore, NAAT is quickly becoming the industry standard in the United States and around the world for blood and plasma testing.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=36327
There are several industry players working in the Nucleic Acid Testing Market, which include bioMeriux, Inc., Bio-rad Laboratories, Inc., Abbott Laboratories, Hoffmann La Roche Ltd.
Qiagen N.V., Becton, Dickinson and Company, Myriad Genetics, Inc.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights| Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian